ArticleBMC genomics2026
A genome-wide association study to identify the genetic loci underlying carbapenem resistance in Acinetobacter baumannii.
Article in BMC genomics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCarbapenem-resistant Acinetobacter baumannii (CRAB) presents a significant public health concern, and is recognized as a key contributor to the global antimicrobial resistance (AMR) crisis. This study applied a bacterial genome-wide association study (bGWAS) framework to identify genetic factors beyond the canonical carbapenemase OXA-23, that may contribute to carbapenem resistance.
methodsA. baumannii isolates with publicly available whole-genome sequencing (WGS) data and carbapenem-specific antimicrobial susceptibility testing (AST) results were compiled (n = 1,601). Unitigs were extracted from de novo assemblies, and single-nucleotide polymorphisms (SNPs) were called from raw sequence reads mapped to seven selected reference genomes. The unitig- and SNP-based genome-wide association analyses were carried out, including conditional analyses based on the known resistance determinants. Structural analysis was performed for the select candidate mutations.
resultsThe population was highly clonal and comprised ten lineages, including three predominantly resistant lineages (ST1, ST2, and ST32). Known CRAB-associated loci, including OXA-23, the RND efflux pump regulator AdeL, and OXA-66 variants (Ile129Leu and Leu167Val), were readily identified. Structural analysis of mutations identified outer-membrane proteins as potential candidate loci, however these loci were not supported in the conditional analyses across all reference genomes. The candidate loci supported in the conditional analysis across reference genomes included an amino acid substitution in a LysR-type regulator adjacent to the biofilm-associated operon pgaABCD, and an intergenic substitution located between enzymes involved in LPS remodeling.
conclusionsOXA-23 is the major determinant of carbapenem resistance in A. baumannii. Additional resistance mechanisms may become significant in the absence of OXA-23, including efflux pump regulation (AdeL), membrane permeability (OprD, DcaP), lipopolysaccharide (LPS) transport (PqiB), LPS remodeling (acyltransferase, glycosyltransferase), and biofilm formation (LysR). Integration of the conditional analysis based on known resistance determinants and a multi-reference mapping framework may improve the detection and prioritization of candidate associations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.